Reports for LORAZEPAM
Ingredient
LORAZEPAM
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2021-12-20 | 2021-12-30 | 151603 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2022-01-12 | 2022-01-18 | 152589 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION LIQUID | Resolved | 2022-03-14 | 2023-07-28 | 156638 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION | Resolved | 2017-04-13 | 2017-11-06 | 6750 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION | Resolved | 2017-11-23 | 2018-02-07 | 30518 |
| LORAZEPAM INJECTION USP | 4MG | SOLUTION | Resolved | 2020-11-06 | 2022-01-25 | 127901 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2025-09-10 | 2025-09-24 | 266909 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| ATIVAN | 1MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269846 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269826 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269840 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269837 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269831 |
| ATIVAN | 0.5MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269843 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 |